This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Advinus Therapeutics Private Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: **Inventor Profile: Sachin Thorat - Innovator in Adenosine Receptor Antagonists**
Introduction
Sachin Thorat is a notable inventor based in Hinjewadi, India, recognized for his contributions in the field of medicinal chemistry. He has made significant strides in developing innovative therapies aimed at treating a variety of neurological and systemic disorders. With one patent to his name, he has proven his capability as an inventive and impactful researcher.
Latest Patents
Sachin Thorat holds a patent for "Fused tricyclic compounds as adenosine receptor antagonist." This groundbreaking patent encompasses a range of fused tricyclic compounds that serve as A2A adenosine receptor antagonists. The compounds may be formulated as tautomers, polymorphs, stereoisomers, prodrugs, solvates, or pharmaceutically acceptable salts. The applications of these compounds extend to treating various conditions including Parkinson’s disease, Alzheimer's disease, neurodegenerative disorders, inflammation, and many others. The work done by Sachin is crucial for advancing therapeutic strategies for complex health challenges.
Career Highlights
Sachin is currently affiliated with Advinus Therapeutics Private Limited, where he contributes to research and development initiatives that focus on innovative drug discovery and development. His work is essential in the advancement of pharmaceutical compounds that could potentially lead to groundbreaking therapies for debilitating diseases.
Collaborations
Throughout his career, Sachin Thorat has collaborated with esteemed colleagues such as Dinesh Barawkar and Sujay Basu. These collaborations are vital for fostering innovation and enhancing the research efforts within the organization, thereby contributing to a shared goal of improving healthcare outcomes.
Conclusion
Sachin Thorat’s work exemplifies the spirit of innovation in the pharmaceutical domain. His patent on adenosine receptor antagonists opens avenues for the treatment of a myriad of conditions, underscoring the significance of his contributions to medical science. As he continues to build on his research, Sachin Thorat remains a pivotal figure in the quest for effective therapies to combat serious health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile